Both will be taken twice a day in pill form during or after meals. Neither the participant nor the study doctors will be able to influence which one she receives. She will begin taking her study drug after chemotherapy treatments and will continue to take it until her breast cancer has progressed or until she has side effects that would cause her doctors to change the treatment. During the study participation, the participant will be asked to visit her doctor and have routine blood tests performed on a monthly basis, as well as other tests to evaluate her tumor every three months. She will also be asked to keep a log in which she will record the date and time she takes the study drug, as well as any symptoms she may be experiencing.
Drugs often have side effects.
Participants should discuss the drugs used in this study with their physician. The researchers do not know if the participant will benefit personally from this study, but the hope is that her tumor may be stabilized. Alternative treatments that could be considered include different chemotherapy drugs, combinations of chemotherapy drugs, or no further treatment. The participant's doctor can provide detailed information about her disease and the benefits of various treatments and options available. Please be sure to have the name of the study and the study number ready.